<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Holden Finnegan | Activity</title>
	<link>https://www.catswannabecats.com/members/relishfriend66/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/relishfriend66/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Holden Finnegan.</description>
	<lastBuildDate>Sun, 28 Jun 2026 07:29:42 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">155cf6b324a87f46e3e0948871da2103</guid>
				<title>Holden Finnegan posted an update: Erdheim-Chester disease (ECD) is a rare entity throughout [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/24010/</link>
				<pubDate>Sun, 08 Jun 2025 11:08:58 -0400</pubDate>

									<content:encoded><![CDATA[<p>Erdheim-Chester disease (ECD) is a rare entity throughout the world. This is the first case reported in Nepal. ECD is a rare aggressive, non-Langerhan&#8217;s histocytosis of unknown origin with classical histological features. The patient usually presents with bone pain or skeletal symptoms along with other constitutional syndrome. Although, no&hellip;<span class="activity-read-more" id="activity-read-more-24010"><a href="https://www.catswannabecats.com/activity/p/24010/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9f0036fd7810ea2c12b08dbd177eb044</guid>
				<title>Holden Finnegan posted an update: This research aims to provide simultaneous predictions of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20832/</link>
				<pubDate>Fri, 06 Jun 2025 11:43:58 -0400</pubDate>

									<content:encoded><![CDATA[<p>This research aims to provide simultaneous predictions of tomato paste&#8217;s multiple quality traits without any sample preparation by using a field-deployable portable infrared spectrometer. A total of 1843 tomato paste samples were supplied by four different leading tomato processors in California, USA, over the tomato seasons of 2015, 2016, 2017,&hellip;<span class="activity-read-more" id="activity-read-more-20832"><a href="https://www.catswannabecats.com/activity/p/20832/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c2e246fcf83bb467fa5fcfe90f236c8c</guid>
				<title>Holden Finnegan posted an update: Prohibitin 2 (PHB2), an inner mitochondrial membrane (IMM) [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18976/</link>
				<pubDate>Wed, 04 Jun 2025 11:43:39 -0400</pubDate>

									<content:encoded><![CDATA[<p>Prohibitin 2 (PHB2), an inner mitochondrial membrane (IMM) protein, has recently been identified as a novel receptor involved in parkin-mediated mitophagy. In the field of veterinary medicine, the role of PHB2 in parkin-mediated mitophagy was described, for the first time, in urothelial cells of cattle, naturally infected with bovine&hellip;<span class="activity-read-more" id="activity-read-more-18976"><a href="https://www.catswannabecats.com/activity/p/18976/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8b11767804bc37116ad6410dc1637f2b</guid>
				<title>Holden Finnegan posted an update: Prohibitin 2 (PHB2), an inner mitochondrial membrane (IMM) [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18932/</link>
				<pubDate>Wed, 04 Jun 2025 11:36:08 -0400</pubDate>

									<content:encoded><![CDATA[<p>Prohibitin 2 (PHB2), an inner mitochondrial membrane (IMM) protein, has recently been identified as a novel receptor involved in parkin-mediated mitophagy. In the field of veterinary medicine, the role of PHB2 in parkin-mediated mitophagy was described, for the first time, in urothelial cells of cattle, naturally infected with bovine&hellip;<span class="activity-read-more" id="activity-read-more-18932"><a href="https://www.catswannabecats.com/activity/p/18932/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c444a91b5d1e7af3aa1e1e7c8de7a8a7</guid>
				<title>Holden Finnegan posted an update: Prohibitin 2 (PHB2), an inner mitochondrial membrane (IMM) [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18846/</link>
				<pubDate>Wed, 04 Jun 2025 11:20:40 -0400</pubDate>

									<content:encoded><![CDATA[<p>Prohibitin 2 (PHB2), an inner mitochondrial membrane (IMM) protein, has recently been identified as a novel receptor involved in parkin-mediated mitophagy. In the field of veterinary medicine, the role of PHB2 in parkin-mediated mitophagy was described, for the first time, in urothelial cells of cattle, naturally infected with bovine&hellip;<span class="activity-read-more" id="activity-read-more-18846"><a href="https://www.catswannabecats.com/activity/p/18846/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5d0ba7afbd84fe26e2772fe3ca1f6856</guid>
				<title>Holden Finnegan posted an update: Addressing the vulnerability and unique needs of homeless [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/17892/</link>
				<pubDate>Tue, 03 Jun 2025 10:47:05 -0400</pubDate>

									<content:encoded><![CDATA[<p>Addressing the vulnerability and unique needs of homeless populations during pandemics has been a major component of the Canadian federal response to the COVID-19 crisis. Rural and remote communities, however, have received little to no funding to aid in their care of homeless people during the pandemic. Similarly, there has been little to no&hellip;<span class="activity-read-more" id="activity-read-more-17892"><a href="https://www.catswannabecats.com/activity/p/17892/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">029f1fa8175280f7c5ee64c5629dc7e5</guid>
				<title>Holden Finnegan posted an update: These results, in combination with our paleoclimate species [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/12498/</link>
				<pubDate>Sun, 01 Jun 2025 10:52:32 -0400</pubDate>

									<content:encoded><![CDATA[<p>These results, in combination with our paleoclimate species distribution modelling, support the idea that currently disjunct patches of dry forest were more connected in the recent past, probably during the Middle and Late Pleistocene. This notion fits the major predictions of the Pleistocene Arc Hypothesis and illustrates the importance of&hellip;<span class="activity-read-more" id="activity-read-more-12498"><a href="https://www.catswannabecats.com/activity/p/12498/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">440ef1a4643a1863c51988ea8c98d56c</guid>
				<title>Holden Finnegan posted an update: essment are mandatory in order to maximize patient care. [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/4820/</link>
				<pubDate>Sat, 31 May 2025 14:10:04 -0400</pubDate>

									<content:encoded><![CDATA[<p>essment are mandatory in order to maximize patient care.</p>
<p> The CFTR modulator tezacaftor/ivacaftor was efficacious and generally safe and well tolerated in Phase 3 studies in participants ≥12 years of age with cystic fibrosis (CF) homozygous for the F508del-CFTR mutation or heterozygous with a residual function-CFTR mutation (F/F or F/RF r&hellip;<span class="activity-read-more" id="activity-read-more-4820"><a href="https://www.catswannabecats.com/activity/p/4820/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">738fccee78d4c43b5111ef65125ce96e</guid>
				<title>Holden Finnegan became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/4770/</link>
				<pubDate>Sat, 31 May 2025 14:03:36 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>